Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 2
1952 2
1953 1
1954 2
1956 4
1958 2
1959 1
1960 7
1961 10
1962 16
1963 18
1964 10
1965 4
1966 11
1967 15
1968 19
1969 11
1970 17
1971 28
1972 30
1973 27
1974 27
1975 51
1976 36
1977 75
1978 107
1979 122
1980 128
1981 124
1982 137
1983 119
1984 161
1985 158
1986 202
1987 220
1988 241
1989 277
1990 300
1991 319
1992 354
1993 355
1994 399
1995 458
1996 570
1997 565
1998 578
1999 634
2000 713
2001 779
2002 970
2003 1030
2004 1242
2005 1445
2006 1625
2007 1672
2008 1928
2009 2045
2010 2474
2011 2749
2012 3066
2013 3444
2014 3476
2015 3796
2016 3954
2017 4244
2018 4492
2019 4894
2020 5837
2021 6909
2022 7528
2023 7267
2024 3082

Text availability

Article attribute

Article type

Publication date

Search Results

78,294 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Tsz-Ming
Page 1
Did you mean tse ming fai (3 results)?
Targeting UGCG Overcomes Resistance to Lysosomal Autophagy Inhibition.
Jain V, Harper SL, Versace AM, Fingerman D, Brown GS, Bhardwaj M, Crissey MAS, Goldman AR, Ruthel G, Liu Q, Zivkovic A, Stark H, Herlyn M, Gimotty PA, Speicher DW, Amaravadi RK. Jain V, et al. Cancer Discov. 2023 Feb 6;13(2):454-473. doi: 10.1158/2159-8290.CD-22-0535. Cancer Discov. 2023. PMID: 36331284 Free PMC article.
To elucidate LAI resistance, proteomics and immunoblotting demonstrated that LAI induced lipid metabolism enzymes in multiple cancer cell lines. ...Although UGCG inhibition decreased LAI-induced GMM and augmented cell death, UGCG overexpression led to LAI …
To elucidate LAI resistance, proteomics and immunoblotting demonstrated that LAI induced lipid metabolism enzymes in multiple …
Real-World Evidence of the Clinical and Economic Impact of Long-Acting Injectable Versus Oral Antipsychotics Among Patients with Schizophrenia in the United States: A Systematic Review and Meta-Analysis.
Lin D, Thompson-Leduc P, Ghelerter I, Nguyen H, Lafeuille MH, Benson C, Mavros P, Lefebvre P. Lin D, et al. CNS Drugs. 2021 May;35(5):469-481. doi: 10.1007/s40263-021-00815-y. Epub 2021 Apr 28. CNS Drugs. 2021. PMID: 33909272 Free PMC article.
In turn, the clinical benefits achieved may translate into lower economic burden. Real-world evidence of the comparative effectiveness of LAI is needed to understand the potential benefits of LAI outside of the context of clinical trials. ...Comparative studies repo …
In turn, the clinical benefits achieved may translate into lower economic burden. Real-world evidence of the comparative effectiveness of …
Aripiprazole Lauroxil: A Review in Schizophrenia.
Frampton JE. Frampton JE. Drugs. 2017 Dec;77(18):2049-2056. doi: 10.1007/s40265-017-0848-4. Drugs. 2017. PMID: 29177572 Review.
Thus, aripiprazole lauroxil LAI extends the treatment regimen options for patients with schizophrenia; as with other LAI formulations of antipsychotic agents, it can be particularly recommended for patients with recurrent relapses related to nonadherence to oral pre …
Thus, aripiprazole lauroxil LAI extends the treatment regimen options for patients with schizophrenia; as with other LAI formu …
[LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN SCHIZOPHRENIA].
Teitelbaum A, Kodesh A. Teitelbaum A, et al. Harefuah. 2019 Jul;158(7):453-457. Harefuah. 2019. PMID: 31339245 Review. Hebrew.
Several studies comparing LAI AP with oral antipsychotics in schizophrenia have been performed, in which RCTs (considered to be the 'gold standard' for clinical trial design) generally show no benefit for LAI AP over oral drugs, whereas observational studies do. The …
Several studies comparing LAI AP with oral antipsychotics in schizophrenia have been performed, in which RCTs (considered to be the ' …
Treatment Journey From Diagnosis to the Successful Implementation of a Long-Acting Injectable Antipsychotic Agent in Young Adults With Schizophrenia.
Kane JM, Mychaskiw MA, Lim S, Suett M, Tian M, Rubio JM. Kane JM, et al. J Clin Psychiatry. 2023 Apr 19;84(3):22m14544. doi: 10.4088/JCP.22m14544. J Clin Psychiatry. 2023. PMID: 37074300 Free article.
Median (range) time between diagnosis and first LAI was 289.5 (0-2,171) days, time between LAI initiation and successful implementation was 90.0 (90-1,061) days, and time to LAI discontinuation after successful implementation was 166.5 (91-799) days. Before …
Median (range) time between diagnosis and first LAI was 289.5 (0-2,171) days, time between LAI initiation and successful imple …
Therapeutic Drug Monitoring of Long-Acting Injectable Antipsychotic Drugs.
Schoretsanitis G, Baumann P, Conca A, Dietmaier O, Giupponi G, Gründer G, Hahn M, Hart X, Havemann-Reinecke U, Hefner G, Kuzin M, Mössner R, Piacentino D, Steimer W, Zernig G, Hiemke C. Schoretsanitis G, et al. Ther Drug Monit. 2021 Feb 1;43(1):79-102. doi: 10.1097/FTD.0000000000000830. Ther Drug Monit. 2021. PMID: 33196621 Review.
Reported data combined with positron emission tomography evidence indicated a trend toward lower concentrations under LAI administration than under oral medications. However, the available evidence is insufficient to recommend LAI-specific therapeutic reference rang …
Reported data combined with positron emission tomography evidence indicated a trend toward lower concentrations under LAI administrat …
Lipid based intramuscular long-acting injectables: Current state of the art.
Wilkinson J, Ajulo D, Tamburrini V, Gall GL, Kimpe K, Holm R, Belton P, Qi S. Wilkinson J, et al. Eur J Pharm Sci. 2022 Nov 1;178:106253. doi: 10.1016/j.ejps.2022.106253. Epub 2022 Jul 3. Eur J Pharm Sci. 2022. PMID: 35793750 Free article. Review.
Long acting injectables (LAI) have received increased research and commercial interest due to their potential for improving treatment effectiveness and adherence for antipsychotic, antiviral and addiction treatments. A range of materials have been used to formulate LAI …
Long acting injectables (LAI) have received increased research and commercial interest due to their potential for improving treatment …
Resonant signals in the lithosphere-atmosphere-ionosphere coupling.
Chen CH, Sun YY, Zhang X, Gao Y, Wang F, Lin K, Tang CC, Huang R, Xu R, Liu J, Wang Y, Chen C. Chen CH, et al. Sci Rep. 2022 Aug 26;12(1):14587. doi: 10.1038/s41598-022-18887-1. Sci Rep. 2022. PMID: 36028655 Free PMC article.
An instrumental system was established in southwest China (Leshan; LESH) for monitoring vibrations and perturbations in LAI (MVP-LAI). A ground-based Global Navigation Satellite System (GNSS) receiver at the YADU station locates ~ 260 km away that continuously recei …
An instrumental system was established in southwest China (Leshan; LESH) for monitoring vibrations and perturbations in LAI (MVP-L …
Evaluation of satellite Leaf Area Index in California vineyards for improving water use estimation.
Kang Y, Gao F, Anderson M, Kustas W, Nieto H, Knipper K, Yang Y, White W, Alfieri J, Torres-Rua A, Alsina MM, Karnieli A. Kang Y, et al. Irrig Sci. 2022;40(4-5):531-551. doi: 10.1007/s00271-022-00798-8. Epub 2022 Jun 9. Irrig Sci. 2022. PMID: 36172252 Free PMC article.
We found that radiative transfer modeling-based approaches predicted low to medium LAI well, but they significantly underestimated high LAI in highly clumped vine canopies (RMSE ~ 0.97 to 1.27). ...Positive LAI errors of 50% resulted in up to 50% changes in E …
We found that radiative transfer modeling-based approaches predicted low to medium LAI well, but they significantly underestimated hi …
Aripiprazole once-monthly long-acting injectable for the treatment of schizophrenia.
Potkin SG, Preda A. Potkin SG, et al. Expert Opin Pharmacother. 2016;17(3):395-407. doi: 10.1517/14656566.2015.1114100. Expert Opin Pharmacother. 2016. PMID: 26864352 Review.
An extended formulation, aripiprazole 400 mg once-monthly (AOM 400) LAI (AOM LAI), received regulatory approval in the year 2013 for the treatment of schizophrenia. ...AREAS COVERED: This review covers data on the efficacy and tolerability/safety of AOM LAI. …
An extended formulation, aripiprazole 400 mg once-monthly (AOM 400) LAI (AOM LAI), received regulatory approval in the year 20 …
78,294 results
You have reached the last available page of results. Please see the User Guide for more information.